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Abstract: Corneal endothelium is formed of 1 layer of mitochondria-
rich cubic cells whose main role is to maintain corneal transparency.
Corneal endothelial disorders represent group of both inherited and
noninherited and may affect proper vision.
A 36-year-old male patient with suspicion of corneal endothelial
dystrophy underwent visual acuity, intraocular pressure, the basic slit-
lamp examination, anterior segment optical coherence tomography (AS-
OCT) (Visante, Carl Zeiss Meditec, Dublin, CA), and corneal confocal
microscopy in vivo (Rostock Cornea Module, Heidelberg Engineering
Retina Tomograph III, Heidelberg, Germany). During the 3-year obser-
vation the patient reported symptoms mainly in the right eye. Slit-lamp
examination revealed endothelial changes, much more pronounced in
the right eye. Examination by the AS-OCT Visante showed hyperre-
flective dots within the right corneal endothelium. In order to assess
endothelial cell morphology, analysis using corneal confocal micro-
scopy in vivo was performed. Scans revealed presence of single
endothelial deposits and severe cell changes of different morphology
in both eyes. In the right eye, less pronounced changes of the poly-
morphic structure—polygonal guttas in different stages, linear and
branched loss with ‘‘nuclear-like’’ formations and accompanying sedi-
ments. In the left eye, severe homomorphous polygonal ‘‘guttas-like’’
changes with ‘‘nuclear-like’’ formations were observed. Endothelial
cysts’ features were dynamically changing during follow-up time with
different effects on the patient’s clinical state.
Corneal confocal microscopy allows accurate imaging of the endo-
thelial cells and their detailed characteristics. Structural changes within
the endothelial cells are not always proportional to visual acuity and slit-
lamp image. The presented case is an example of an unusual corneal
endothelial syndrome with probably nondystrophic background due tolegala, MD, PhD, , MD,
ska, MD, PhD
Abbreviations: AS-OCT = anterior segment optical coherence
tomography, BCVA = best-corrected visual acuity, CCT = central
corneal thickness, CHEDS = congenital hereditary endothelial
dystrophies, FECD = Fuchs endothelial corneal dystrophy, ICE =
iridocorneal endothelial syndromes, IOP = intraocular pressure,
PEX = pseudoexfoliation syndrome, PPCD = posterior
polymorphous corneal dystrophy, XECD = X-linked endothelial
corneal dystrophy.
INTRODUCTION
T he term ‘‘dystrophy’’ is commonly used to describe aninherited disorder, fulfilling certain criteria. In ophthal-
mology, the term ‘‘corneal dystrophy’’ has no strictly defined
borders. It is a group of corneal disorders usually with the
following features: inherited, noninflammatory, typically bilat-
eral, symmetric, slowly progressive (regression in dystrophy
development is unusual), and without relationship to environ-
mental or systemic factors.1 However, in some cases corneal
dystrophies can coexist with other systemic disabilities (macu-
lar dystrophy or amyloidosis, which is often called lattice
dystrophy type II, Schnyder dystrophy) or can develop unilat-
eral (posterior polymorphous endothelial dystrophy). On the
other hand, there are some corneal abnormalities which are
excluded from the corneal dystrophies group, despite fulfilling
defined conditions (such as ‘‘cornea plana’’—inherited, bilat-
eral, usually not related to systemic abnormalities).2 Corneal
endothelial dystrophies concern diseases characterized by cor-
neal endothelial cells layer abnormalities, what usually leads to
slowly progressive degeneration of corneal endothelium,
decreasing of cells density and affecting visual acuity.3
On the contrary, there are nondystrophic endothelial syn-
dromes that include variants of iridocorneal endothelial syn-
dromes (ICE) and endothelial (preendothelial) deposits. In such
cases, changes might be observed unilaterally with tendency for
both progression and regression while they are secondary
pronunciation of other eye disorders (inflammatory changes,
iris and iridocorneal angle pathologies, iatrogenic repercus-
sion).4,5
The aim of this report is to describe abnormal phenotype of
corneal endothelium in a 36-year-old patient, with features of
clinical regression accompanied by progressive endothelial
pathology.
CASE PRESENTATION
The study was approved by the institutional review board
of the Medical University of Silesia, Katowice, Poland, and
btained from the patient after providing
nature and possible consequences of
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TABLE 1. Visual Acuity and Endothelial Layer Measurements Including Density of Endothelial Cells and Endothelial Cysts
Right Eye Left Eye
Year
Visual
Acuity
Endothelial
Cells Density/mm2
Endothelial
Cysts Density/mm2
Visual
Acuity
Endothelial
Cells Density/mm2
Endothelial
Cysts Density/mm2
2012 0.3 1650 89 570 17 1.0 2050 121 800 23
2013 0.5 1520 76 498 24 1.0 2031 98 820 31
2014 0.7 1510 48 439 43 1.0 2020 116 840 14
provement of visual acuity) and progressive loss of endothelial cells in right
Right cornea
Left cornea
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Right Eye Left Eye
FIGURE 1. Slit-lamp photographs of anterior segment after
mydriasis. Posteriorly localized changes of alveolar and linear
morphology, much more pronounced in the right eye. During
Smedowski et al Medicine  Volume 94, Number 9, March 2015A 36-year-old patient with suspicion of corneal endothelial
dystrophy underwent the following examination: best-corrected
visual acuity (BCVA), intraocular pressure (IOP), refraction,
the basic slit-lamp examination including anterior and posterior
segment examination before and after mydriasis, corneal
imaging with anterior segment optical coherence tomography
(AS-OCT) including central corneal thickness (CCT) and cor-
neal topography measurements (Visante, Carl Zeiss Meditec,
Dublin, CA), and corneal confocal microscopy in vivo (Rostock
CorneaModule, Heidelberg Engineering Retina Tomograph III,
Heidelberg, Germany). During the 3-year follow-up, the patient
reported symptoms of decreased and blurred vision mainly in
the right eye. In anamnesis, no history of any type of ocular
surgery (including refractive surgery), no family history of
ocular diseases, no use of contact lenses or eye drops usage
at present or in the past. In blood samples, no inflammatory
markers elevation was observed (C-reactive protein level,
erythrocyte sedimentation rate). The patient was referred to
our outpatient clinic after he underwent detailed ophthalmic
examination in a foreign clinic (the Netherlands), where corneal
changes have been described as a case of an ‘‘unknown
dystrophy.’’
During the 3-year follow-up the clinical status of the
patient changed. Decimal BCVA over the years of observation
ranged from 20/63 to 20/25 for the right eye and was constant at
20/20 for the left eye (Table 1). IOP values were within normal
limits (below normative 21 mm Hg). Slit-lamp examination
revealed posteriorly localized changes of alveolar and linear
morphology, much more pronounced in the right eye. No other
abnormalities were described within the anterior and posterior
segments of both eyes, including gonioscopy and corneal
topography results (Figure 1). Mean CCT was 499 15mm
in the right and 500 19mm in the left eye; corneal pachy-
metric maps showed no abnormalities. Examination with the
AS-OCT Visante showed hyperreflexive dots and discreet
hyperdensity of corneal stroma mostly within the right cornea
(Figure 1).
In order to assess endothelial cell morphology, analysis
using corneal confocal microscopy in vivo was performed.
The scans revealed presence of massive endothelial deposits in
the right eye and severe cell changes of different morphology in
both eyes. In the right eye, we found less pronounced changes of
the polymorphic structure—polygonal guttas in different stages,
linear and branched loss with ‘‘nuclear-like’’ formations, and
cells polymegathism (Figure 2A–L). In the left eye, more severe
monomorphous polygonal ‘‘guttas-like’’ changes with small
‘‘nuclear-like’’ formations, with no signs of polymegathism,
During follow-up time there was visible regression in clinical state (im
cornea and constant state in left one.were visible (Figure 2 A-L). Endothelial cells density and density
of endothelial cysts, determined using ‘‘cell count’’ module of
corneal confocal microscopy, are presented in Table 1.
follow-up time visible regrouping of endothelial changes that
became eccentrically localized. AS-OCT Visante revealed hyperre-
flective dots within endothelium of the right cornea and discreet
hyperdensity of corneal stroma in both eyes.
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FIGURE 2. A–L. Corneal confocal microscopy in vivo. Over the years 2012 to 2014 in right cornea reduction of sediments (1) and
ith
ou
Medicine  Volume 94, Number 9, March 2015 Cystic Corneal EndotheliumBetween regular examination visits, we observed dynamic
regression in clinical status, which was concurrent with BCVA
improvement. Endothelial changes in the right eye presented
regressive features for their localization (clearing of central
corneal area) as well as for decreasing presence of sediments;
however, progressive endothelial cells loss was observed.
Regression was accompanied by releasing of endothelial depos-
its material from endothelium to anterior chamber causing
aqueous humor convection (probably noninflammatory). Both
lenses showed no visible features of pseudoexfoliation (PEX)
syndrome. In the left eye, endothelial abnormalities and clinical
status remained stable.
DISCUSSION
In the described case, suspected corneal endothelial dys-
trophy presents some features that could be characteristics for
posterior corneal dystrophies, however, not fully matching any
of already described dystrophies. There is also no clear relation
to any nondystrophic secondary endothelial pathology. Changes
appeared bilaterally, but they have asymmetric morphology.
Severity of changes did not correlate with clinical state and
presence of polygonal, polymorphous guttas in different stage (2) w
were observed. In left cornea–dominated polygonal, homomorph(based on anamnesis) seemed not to be inherited.
In the case of posterior polymorphous corneal dystrophy
(PPCD), changes appear mostly bilaterally and have similar
Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.morphology, however, can also be asymmetric. Clinical state
usually does not correlate with severity of changes. In endo-
thelial cells, dominant features are polymegathism, vesicular,
band, and diffuse lesions. Additionally, peripheral iridocorneal
adhesions and elevated IOP can appear.6 In Fuchs endothelial
corneal dystrophy (FECD) characteristics are symmetric guttas
of different size and round shape, polymegathism and pleo-
morphism of cells, with presence of corneal edema due to
degeneration of the corneal endothelium. Changes involve
usually both eyes.1 In congenital hereditary endothelial dystro-
phies (CHEDs), changes are bilateral, symmetric or asym-
metric. Massive endothelial cells degeneration cause corneal
edema from the time of birth or shortly after. In cell structure,
the characteristic features are atrophy, vacuolization, and meta-
plasia with keratotic epithelial cells.7,8 X-linked endothelial
corneal dystrophy (XECD)—with characteristic ‘‘moon crater–
like’’ endothelial changes—develop in early age.9 Based on
description of endothelial dystrophies, there might be sim-
ilarities observed between changes in the patient’s right eye
and PPCD; however, the expression is not typical. The left eye
does not present any features of already known dystrophies. In
this case, very likely explanation is a coexistence of 2 different
‘‘nuclear-like’’ creations (3) and linear and branched dropouts (4)
s guttas in different stage (2).types of corneal dystrophies or 2 different phenotypes of the
same dystrophy. Descriptions of this kind of rare combinations
can be found in the literature.10–12 Considering 3-year follow-
www.md-journal.com | 3
up of presented patient’s disease, it is rather unlikely to search
for dystrophic background, mostly due to regression in patient’s
clinical state that is untypical for dystrophic intercourse. In
comparison with available confocal description of ICE syn-
drome, where authors describe presence of epithelioid cells
within endothelium, hyperreflectivity of cells nuclei, sac-like
blisters, and ruptured blisters, revealed no such cell abnormal-
ities in the presented report.4,13,14
CONCLUSION
Corneal confocal microscopy allows accurate imaging of
the endothelial cells and their detailed characteristics. Structural
changes within the endothelial cells are not always proportional
to visual acuity and slit-lamp image. The presented case is an
example of an unusual corneal endothelial phenotype with
probably nondystrophic background due to observed dynamics
of endothelial changes with regressive tendency.
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